The keywords highlight the necessity of refolding and encapsulation processes to overcome non-functional protein states. Preventing irreversible aggregation during synthesis ensures high yields of bioactive supramolecular structures.

Rapid systemic clearance and enzymatic degradation limit the therapeutic efficacy of monomeric proteins. Increasing molecular size and stability through fusion prevents premature renal filtration and proteolysis.